Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.

about

Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.

Item

http://www.wikidata.org/entity/Q53766555

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Reduced late urinary toxicity ...... for localized prostate cancer.

@en

Reduced late urinary toxicity ...... for localized prostate cancer.

@nl

type

Item

label

Reduced late urinary toxicity ...... for localized prostate cancer.

@en

Reduced late urinary toxicity ...... for localized prostate cancer.

@nl

prefLabel

Reduced late urinary toxicity ...... for localized prostate cancer.

@en

Reduced late urinary toxicity ...... for localized prostate cancer.

@nl

P1476

Reduced late urinary toxicity ...... for localized prostate cancer

@en

P2093

A Cruz-Conde

http://www.w3.org/2001/XMLSchema#string

A Zapatero

http://www.w3.org/2001/XMLSchema#string

C Martin de Vidales

http://www.w3.org/2001/XMLSchema#string

F García-Vicente

http://www.w3.org/2001/XMLSchema#string

G Pozo

http://www.w3.org/2001/XMLSchema#string

L Fernández-Banda

http://www.w3.org/2001/XMLSchema#string

O Liñán

http://www.w3.org/2001/XMLSchema#string

P Castro

http://www.w3.org/2001/XMLSchema#string

P2860

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last?

A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraints.

The relationship between external beam radiotherapy dose and chronic urinary dysfunction--a methodological critique.

Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.

Predicting toxicity in radiotherapy for prostate cancer.

Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.

P2888

s12094-017-1655-9

P304

1161-1167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1655-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

D Büchser

M Roch

P577

2017-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28374321

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy